craniopharyngioma and pituitary tumors. Only two patients received radiation in the range classified as LD therapy. This was administered for hypertrophic tonsils in one patient in whom thyroid cancer developed later; the second patient had received a nasal implant in kindergarten.
There were seven men and seven women in the HD group, whereas both patients in the LD group were women. Radiation therapy was administered between the ages of 1 and 53 years in patients who received HD treatments and at the age of 3 years in one and 7 years in the other patient who received LD therapy. The age of the patients when the radiation-induced meningioma was diagnosed ranged from 18 to 63 years (mean 37.9 years) for the HD and 37 to 53 years (mean 45 years) for the LD group; the mean age for both groups was 38.8 years. The latency or induction period ranged from 6 to 58 years (mean 24.6 years) for the HD and 34 to 46 years (mean 40 years) for the LD group. The induction period was 26.5 years for the two groups combined.
Presentation was typical for a meningioma series and included seizures, mental deterioration, and signs of increased intracranial pressure. Two patients had multiple lesions at presentation of disease, multiple lesions developed on recurrence in three ( Fig. 1 ), and all five had received HD radiation. Among patients who received HD treatments, 12 had basal lesions, one had basal and calvarial tumors, and two lesions were located along the calvaria. For the two patients in the LD group, both lesions were basally situated. Five (31%) of 16 tumors had atypical features and another one (6%) was classified as malignant. The meningothelial tumor type was predominant in our study. Testing for hormone receptors was performed in 11 specimens. All 11 contained PRs, whereas only three of 11 contained ERs.
The PCNA ranged from 0 to 15% in nine cases and Ki-67 monoclonal antibody labeling ranged from 1 to 3% in four cases.
Flow cytometry DNA analysis was performed in 11 samples obtained in eight patients (Table 3 ). An aneuploid cell population with low S phase was observed in two cases (18%) of recurrent meningioma (in one it was the second recurrence; in the other it was the third recurrence). A diploid cell population with low S phase was found in seven cases; diploid cells with increased S phase were observed in two cases. High S phase (the S phase fraction is equal to the percentage of cells in the S phase of the cell cycle, the stage when DNA replication occurs) is a predictor of future tumor progression. Both of these patients had recurrent meningioma. In one of them (Case 5), flow cytometry showed a diploid cell population with a high S phase of 11%. This patient had a second recurrence 15 months later and at that time the flow cytometry result was reported as an aneuploid cell population with low S phase.
Cytogenetic studies were performed in nine samples obtained in seven patients (Table 4) ; three of these samples have been previously reported. 94, 95 All tumors showed multiple complex chromosome aberrations (Fig. 2) , resulting in either pseudodiploid or hypodiploid karyotypes. In this study, the most frequent structural aberrations were found on chromosomes 1p and 6q. Aberrations of chromosome 1 were identified in 89% of cases. These aberrations resulted from unbalanced translocations of 1p with different chromosome partners (Table 4 ). The resulting aberrations were essentially deletions of chromosome 1p, and were identified in seven (78%) of the nine samples. Six samples (67%)
showed deletion or loss of chromosome 6. Loss or deletion of chromosome 22 was found in five samples (56%). Combinations of chromosome aberrations including 1p, 6q, and 22 were recognized in four samples (44%) in three patients (Cases 5, 11, and 13); two of them experienced very aggressive tumor behavior.
One patient (Case 5) suffered three recurrences during a period of 6 years and underwent three surgical treatments; therefore this case is particularly informative. Samples obtained in this patient showed loss of 1p, 6q, and deletions of both chromosome 22 in the first chromosome analysis. These aberrations comprised the only clone identified and are characteristic of meningioma. In the second chromosome analysis, however, totally unrelated chromosome aberrations were found, probably indicating unstable therapy-related aberrations. In the third chromosome analysis the original abnormal clone was again identified in addition to other unrelated abnormal clonal cells.
Recurrence was seen in all 12 patients treated with HD radiation in whom 2 years of follow up was available and in one of the two patients (one was lost to follow up) who received LD therapy (Table 5 ). The overall recurrence rate was 100%; in 13 patients with a follow-up period of more than 2 years, all experienced recurrence. The period from surgery to recurrence ranged from 9 months to 7 years (mean 29.42 Ϯ 5.46 months) in the HD group and was 9 years in the one recurrence in the LD group. The overall time to recurrence averaged 35.46 Ϯ 7.8 months. A second recurrence was encountered in 62% (seven of 12 patients in the HD group and one from the LD group). These recurrences took place 11 months to 7 years after the second surgery (28 Ϯ 10.71 months). Two (17%) of 12 patients in the HD group had a third recurrence, one at 4 months and one at 21 months postsurgery (mean 12.5 Ϯ 12 months). Twenty-seven surgeries were performed in 16 patients with radiation-induced meningioma and the total number of recurrences in 13 patients with follow-up periods of more than 2 years was 22. One patient died of disease progression; this patient underwent two resections and one GKS during a period of 5 years (Table 5) .
Discussion
A dose-effect relationship has been documented: there is an increasing risk of CNS tumors developing with increasing doses of radiation. 7, 41, 50, 55, 58, 84, 85 Several other pertinent factors should be noted. The period of delivery, fraction size, weekly dose, field size, and method used all contribute to the risk of neoplastic induction. 7, 9, 18, 19, 21, 27, 37, 50, 58 Table 6 lists the reported radiation-induced meningiomas in the lit- 1) tumor must arise in the irradiated field 2) histological features must differ from those of any previous neoplasm 3) a sufficient latency or induction period following radiation must elapse before meningioma is diagnosed (usually Ͼ5 yrs) 4) no family history of phakomatosis 5) tumor must not be recurrent or metastatic 6) tumor must not be present prior to radiation therapy erature. It has also been recognized that the developing CNS is especially sensitive to neoplastic induction, particularly when high doses of radiation are delivered in young patients.
Harrison, et al., 38 classified radiation-induced meningiomas into three groups based on the amount of radiation administered, as follows: 1) low dose (Ͻ 10 Gy); 2) moderate dose (10-20 Gy); and 3) high dose (Ͼ 20 Gy). It has been reported that meningiomas occur more frequently after LD radiation, whereas gliomas and sarcomas occur more frequently after higher doses. 16, 41, 71 This may be a spurious conclusion because of the thousands of patients who received LD radiation for tinea capitis and in whom meningiomas were subsequently reported. Although earlier case reports existed, the initial recognition of radiation-induced meningioma came in the first half of the 20th century in patients who had received LD radiation for tinea capitis according to the Adamson-Kienböck method. 12, 32, 35, 36, 56, 62, 65, 81, 85, 86, 101, 103 This procedure delivered virtually no radiation to tissues below the scalp, skull, and meninges. 2 Therefore, there was little risk of developing gliomas or sarcomas. Now that this type of treatment has been abandoned, the majority of radiation-induced meningioma as well as gliomas and sarcomas occur in patients receiving HD radiation (Table 6 ). * ALL = acute lymphoblastic leukemia; ant clin = anterior clinoid; CPA = cerebellopontine angle; cranio = craniopharyngioma; CS = cavernous sinus; for jug = foramen jugulare; grv = groove; hyp ton = hypertrophic tonsils; neuro = neuroblastoma; NHL = non-Hodgkin lymphoma; olf = olfactory; parasag = parasagittal; pit ad = pituitary adenoma; rec = recurrence; retroaur = retroauricular; RT = radiation therapy; sph = sphenoid; subep = subependymoma; tent = tentorium; tm = tumor; vent = ventricle.
† Doses for HD treatment were greater than 20 Gy and for LD treatment doses were less than 10 Gy. 
meningoth diploid w/ low S phase meningoth diploid w/ low S phase ----(DI-1; %S-1) (DI-2; %S-1) 5 meningoth diploid w/ low S phase meningoth diploid w/ high S phase meningoth aneuploid w/ (DI-1; %S-3) (DI-1; %S-11) low S phase (DI-1.5; %S-4)
* DI = DNA index; FR = fraction range; int = intermittent; meningoth = meningotheliomatous; trans = transitional; --= not done.
It has also been noted that radiation-induced meningiomas differ from nonradiation-induced meningiomas in several key aspects. They tend to behave more aggressively, 30 
Cytogenetic Analysis
Although both radiation-induced meningiomas and nonradiation-induced meningiomas possess chromosome alterations, there are differences between the two. In nonradiation-induced meningiomas cytogenetic data reveal that 43 to 80% of tumors display a loss or translocation of the long arm of chromosome 22. 20, 22, 60, 73, 88, 90 This apparently involves the tumor suppressor gene found in NF2 and located at 22q12.2. 117 In more aggressive nonradiation-induced meningiomas there appears to be progressive loss of genetic material, indicating an associated loss of tumor suppressor genes. Benign tumors exhibit a normal karyotype or loss of all or part of chromosome 22, whereas atypical or malignant tumors reveal more complex aberrations including the loss of chromosomes 1p, 10, and 14q. Aggressive behavior is correlated with the increasing loss of genetic material. 90, 118 It appears that in radiation-induced meningiomas there is karyotypic instability or the presence of multiple chromosome rearrangements. 20, 48, 118 In radiation-induced meningioma, unlike sporadic meningiomas, NF2 gene inactivation and loss of chromosome 22 are less frequent. Absence of mutations in the NF2 gene in radiation-induced meningiomas and allelic loss of loci on chromosome 22q in only two (29%) of seven cases were reported by Shoshan, et al. Zattara-Cannoni, et al., 119 performed a cytogenetic study of six cases of radiation-induced meningioma, and found specific abnormality on chromosome 1p (der(1)(qter-1p11: 22q12-22pter). The loss of heterozygosity on chromosome 1p was detected in four (57%) of seven cases of radiationinduced meningioma in a study performed by Shoshan, et al. 99 We also note an evolutionary pattern with the loss of chromosome 1p, multiclonality, and a high frequency of unbalanced chromosome rearrangements. This has been reported in some nonradiation-induced meningiomas as well as in a few cases of radiation-induced tumors and patients with recurrent gliomas. 20, 73 Structural abnormalities of chromosome 6 were reported in four of eight cases of meningioma in young children or adolescents. 13 Meningioma usually displays more aggressive behavior when it develops in a young person. In an analysis of eight patients with meningioma, structural abnormalities on chromosome 6 were present in 63%, and in 18% compared with 3% in aggressive and benign tumors, respectively, from a review of the literature. 79 A study by Comtesse, et al., 22 shows that meningiomas can express antigens that elicit an immune response in the host; there are five novel immunogenic antigens expressed in meningioma, three of which are localized on chromosome 6. One of the immunoreactive antigens identified was found to be identical to the gene for the connective tissue growth factor. Two of them are localized on 6q23, and one on 6p21. In our study, deletion or loss of chromosome 6 was observed in 67% of cases (Table 4 ). In two of them (Cases 5 and 13) the deletion occurred in region 6q23; these tumors exhibited very aggressive behavior.
Age at Presentation and Sex Distribution
It is well established that meningiomas arise predominantly in women in the fifth and sixth decades of life. In radiation-induced meningioma, however, this is altered: these meningiomas present in much younger patients, particularly in those receiving higher doses of radiation. In our series, the mean age for patients in the HD category was 37.9 years and in the LD group it was 45 years; the mean age for the combined groups was 38.8 years. These findings are similar to other data in the literature in which the mean age for patients treated with HD radiation ranged from 29.2 to 35 years; 25, 38, 66, 92, 93, 100 for the LD group the range was 45 to 58 years. 38, 66, 81, 86, 101 Approximately two thirds of meningiomas will occur in women, for a 1:2 male/female ratio. Our male/female ratio was 1:1 in the HD and 0:2 in the LD group. This is in contrast to other data in the literature, in which there is a female preponderance in the HD group but a strong male preponderance among those in the LD group. If male and female patients were equally susceptible to radiation-induced meningioma then one would expect a 1:1 ratio in the HD category, in which one should see equal numbers of each sex receiving radiation therapy for tumors. This is consistent with our series, although it runs contrary to the other data in the literature. In patients in the LD group, the majority of the series in the literature are composed of patients receiving radiation therapy for tinea capitis. Because the male population is engaged in outdoor activities more frequently, they are the population most likely to receive therapy for ringworm. Thus the data in the literature display a strong preponderance of male patients. We assume that the small sample size is the reason that both patients with radiationinduced meningioma following LD treatment in our series were female.
Latency or Induction Period
The interval between radiotherapy and detection of the meningioma was inversely related to dose. With HD radiation, the meningiomas in our series developed more rapidly (mean 24.6 years) compared with the LD group (mean 40 years). Reported latencies for radiation-induced meningiomas arising after LD radiation range from 12 to 46 years, 3, 100 although in the majority of studies the mean latencies are between 30 and 40 years. 35, 38, 42, 48, 55, 66, 86, 92, 93, 100, 101 Radiation-induced meningioma resulting from HD radiation have widely ranging latency periods reported in the literature with a low of 3.5 years 89 and a high of 63 years. 48 In the majority of series the reported latencies are in the teens to low twenties. 25, 38, 55, 66, 92, 93, 100 The difference in latency between tumors treated with HD and LD radiation therapy indicates that the worse chromosome injury caused by higher radiation doses elicits more rapid loss of cellular control mechanisms and earlier expression of the neoplastic phenotype.
38,92,93

Site of Tumor and Multiplicity
By definition radiation-induced meningioma must occur along the field of irradiation. Thus to some degree a discussion of location for radiation-induced meningioma is irrelevant. As a result of our referral pattern at the University of Arkansas Skull Base Center, however, the tumors in the majority of our patients were basal in location (81%). This is atypical for most series without this referral bias, in which 33% of nonradiation-induced meningiomas reside along the skull base. One point is worthy of note: because GKS GKS * FU = follow up; mult = multiple; S = surgery; S int = intermittent S phase; Tx = treatment; ϩ = positive. patients with radiation-induced meningioma have received radiation for a previous pathological entity, discovery of a second tumor may be misinterpreted as a recurrence of the original lesion. 4, 49, 77, 82, 102 It is reported that between 0.58 and 2.4% of nonirradiated meningiomas will be multiple lesions, in contrast to radiation-induced meningioma, in which the incidence is reported to range from 4.6 to 29%. One extraordinary case report describes a patient who received radiation for a subependymoma in childhood and in whom 20 separate meningiomas developed later in life. 52 In our series we documented a 31.3% incidence of multiplicity overall and 35.7% within the HD cohort, which is consistent with the literature in general. * Ac = acoustic; astro = astrocytoma; ca = carcinoma; cerebel = cerebellar; chr = chronic; clin = clinoid; convex = convexity; ep = ependymoma; epith = epithelioma; fibro = fibrosarcoma; for mag = foramen magnum; fr = frontal; g ect germin = ganglia ectodermal germinoma; glio = glioblastoma; histio = histiocytoma; lymph = lymphoma; medullo = medulloblastoma; men = meningioma; nasophar = nasopharyngeal; oligo = oligodendroglioma; par = parietal; pineo = pineoblastoma; pst = posterior; retino = retinoblastoma; spongio = spongioblastoma; suprasel = suprasellar; temp = temporal; temp basal = temporobasal; temp par = temporoparietal; ton = tonsils; trabec = trabecular; tub = tuberculum; vasc = vascular; ? = not given.
Histological Findings and Recurrence in RadiationInduced Meningioma
The main histological variations of meningiomas are meningotheliomatous, transitional, and fibroblastic. Similar ratios are reported in the literature for radiation-induced meningioma and nonradiation-induced meningioma. 101 Furthermore, these tumors can be categorized as benign, atypical, or malignant, with reported percentages of 92, 7.2, and 0.8%, respectively. Musa, et al., 66 reported an incidence of 76% benign, 19% atypical, and 4% malignant among radiation-induced meningioma with HD therapy and 90% benign and 10% atypical after LD treatment. Rubinstein, et al., 86 reported four distinctive histological features characteristic of radiation-induced meningioma: 1) a high degree of cellularity; 2) pleomorphic nuclei; 3) numerous multinucleated and giant cells; and 4) nuclei with vacuolated inclusions. Anaplastic tumors will demonstrate loss of architecture, high cellularity, increased mitotic rate, and nuclear pleomorphism. In our series atypia was encountered in 31% of the specimens, which is at the middle of the range reported in the literature (that is, the range is 14-43%). 38, 51, 55, 81, 86, 88, 92, 93, 101 Malignant meningiomas have been defined as atypical tumors with necrosis, brain invasion, distant metastasis, or more than 20 mitotic figures per high-power field. 90 The malignancy rate in our series was 6%, a little lower than in the literature, in which the range is 9.6 to 14%. 92, 93, 101 As might be inferred from the higher rate of anaplasia and malignancy, radiation-induced meningiomas are more aggressive tumors than their nonirradiated counterparts. 36, 38, 81, 86, 93, 101 A recurrence rate of between 18.7 and 25.6% is reported in the literature, which simultaneously documents a 3 to 11.4% rate of recurrence in nonradiation-induced meningioma controls. 81, 86, 93, 101 This can be largely attributed to the propensity for bone invasion in radiation-induced meningioma, which often results in incomplete tumor resection. 38, 86, 101, 106, 117 In our series, a high percentage of our patients had undergone tumor resection at another institution and were only referred to our center following recurrence. Thus, for our series, the recurrence rate is 100%, excluding the patient lost to follow up. Additionally, there appears to be a more rapid rate of recurrence in radiation-induced meningioma. The literature specifies the interval from surgery to recurrence as 6.2 years for patients who receive radiation therapy and 10.5 years for controls who do not receive radiation. 101 The mean time from surgery to recurrence was 2.5 years in the HD population and 9 years in the one patient in the LD population in whom a recurrence developed (mean 2.3 years overall). Additionally, a second recurrence was seen in 62% of our patients and a third recurrence in 17%. This rate is quite high even when compared with other radiation-induced meningiomas in the literature and is most likely a reflection of the referral of skull base tumors to our institution. 86 
Cell Kinetics
The LIs for evaluating cell kinetics, including Ki-67 monoclonal antibody labeling and PCNA, became widely used to provide an indication of a tumor's aggressive behavior and malignancy.
In our study, PCNA and Ki-67 were analyzed in nine and four cases, respectively, and showed changes within the normal range in a majority of cases. Results of these analyses did not reflect future tumor progression, except in one case in which a high PCNA index (Ͼ 15%) correlated with future recurrence. We could not confirm a correlation among cell kinetics, histological findings, and aggressive behavior in these tumors. That is, radiation-induced meningiomas displayed aggressive clinical behavior despite benign histological findings and LIs. Thus, labeling methods such as bromodeoxyuridine, Ki-67, and PCNA may provide useful information in borderline cases, but further investigation is warranted.
All tumor samples possessed PRs, whereas three were found to have ERs. The clinical relevance of this is undetermined; however, it is believed that hormone receptors on meningiomas are not involved in the proliferation rate. 1, 80, 88, 90, 97 Nevertheless, the presence of PRs in meningioma is a favorable prognostic factor, 40 and meningiomas with atypical features are negative for these receptors. 8, 111 Benign meningiomas with PRs are less likely to recur. 29 In our study, the presence of PRs in radiation-induced meningiomas was not correlated with less aggressive behavior.
Management of Radiation-Induced Meningioma
Surgical removal remains the treatment of choice in most cases of meningioma, including radiation-induced lesions. Nevertheless, because of their aggressive nature and other extenuating circumstances they can provide significant challenges to the neurosurgeon. To a great extent, as with other meningiomas, tumor size and location are better determinants of prognosis than histopathological findings. 28 Nevertheless, prior irradiation creates numerous other variables that complicate the management of these tumors. Given the greater propensity of radiation-induced meningioma to recur, an exceptionally wide bone and dural margin should be resected where feasible. 38 With skull base tumors in which wide margins cannot be obtained, the recurrence rate will be higher. Additionally, a surgical approach made through previously irradiated tissue frequently leads to poor wound healing with a greater chance of complications such as wound breakdown and CSF leakage. Extreme vigilance must be applied to the surgical procedure during closure to avoid such complications. In the medically infirm patient or in other situations in which surgical treatment is contraindicated, one is confronted with difficult therapeutic choices. Often the maximum tolerable dose of radiation has already been administered and conventional radiotherapy is not an option. 51 In these patients, stereotactic localization with fractionated irradiation, 7,21,50 radiosurgery, 68, 77 and brachytherapy can be considered. Also, one might need to resort to enrollment of the patient in a protocol for chemotherapy or interferon treatment.
After surgery, recurrence is a much greater concern than with nonradiation-induced meningiomas. More frequent follow up with neuroimaging studies is warranted in this patient population so that therapy can be administered early and aggressively.
Conclusions
Although the evolution of radiotherapy and radiosurgery has greatly reduced exposure of nontarget tissues to radiation, radiation-induced tumors remain an important complication of these procedures. Radiation-induced me-ningiomas display more aggressive behavior than other meningiomas. This includes a higher recurrence rate and a greater incidence of anaplasia and malignancy. These lesions present special challenges to the neurosurgeon and therefore thorough preoperative evaluation is warranted. This evaluation must exclude other radiation-induced complications associated with the tumor, such as occlusive vasculopathy, which can greatly complicate surgery. A greater margin of resection of normal dura and bone surrounding the dura is advised whenever feasible to minimize the risk of recurrence. Lesions along the skull base, where it is difficult to achieve wide margins of resection, present special challenges. The LIs such as Ki-67 and PCNA were not demonstrated to correlate with clinical behavior in our series. Further investigation is warranted to determine their prognostic applicability in radiation-induced meningioma. Resection is the treatment of choice for radiation-induced meningiomas despite the special difficulties previously delineated. When resection is contraindicated, conventional radiotherapy is often not an option because of radiation previously received. In these patients alternatives such as radiosurgery, brachytherapy, and medical treatment should be considered.
